Canada markets open in 7 hours 42 minutes

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
13.06-0.14 (-1.06%)
At close: 04:00PM EDT
13.00 -0.06 (-0.46%)
After hours: 06:05PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 41.15B
Enterprise Value 69.10B
Trailing P/E 44.81
Forward P/E 111.11
PEG Ratio (5 yr expected) 3.78
Price/Sales (ttm)1.51
Price/Book (mrq)0.88
Enterprise Value/Revenue 2.53
Enterprise Value/EBITDA 10.80

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 3-19.48%
S&P500 52-Week Change 327.84%
52 Week High 316.39
52 Week Low 312.77
50-Day Moving Average 313.57
200-Day Moving Average 314.39

Share Statistics

Avg Vol (3 month) 31.56M
Avg Vol (10 day) 31.41M
Shares Outstanding 53.14B
Implied Shares Outstanding 63.15B
Float 81.55B
% Held by Insiders 10.00%
% Held by Institutions 12.51%
Shares Short (Apr 30, 2024) 45.97M
Short Ratio (Apr 30, 2024) 43.71
Short % of Float (Apr 30, 2024) 4N/A
Short % of Shares Outstanding (Apr 30, 2024) 40.20%
Shares Short (prior month Mar 28, 2024) 48.12M

Dividends & Splits

Forward Annual Dividend Rate 40.64
Forward Annual Dividend Yield 44.89%
Trailing Annual Dividend Rate 3188.00
Trailing Annual Dividend Yield 31,424.24%
5 Year Average Dividend Yield 44.73
Payout Ratio 4104.57%
Dividend Date 3Dec 11, 2023
Ex-Dividend Date 4Sept 28, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 3.38%
Operating Margin (ttm)-7.40%

Management Effectiveness

Return on Assets (ttm)1.57%
Return on Equity (ttm)2.12%

Income Statement

Revenue (ttm)4.26T
Revenue Per Share (ttm)1,362.70
Quarterly Revenue Growth (yoy)9.90%
Gross Profit (ttm)N/A
EBITDA 1.09T
Net Income Avi to Common (ttm)144.07B
Diluted EPS (ttm)0.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)457.8B
Total Cash Per Share (mrq)291.78
Total Debt (mrq)5.53T
Total Debt/Equity (mrq)76.05%
Current Ratio (mrq)1.11
Book Value Per Share (mrq)4,635.56

Cash Flow Statement

Operating Cash Flow (ttm)716.34B
Levered Free Cash Flow (ttm)35.08B